(Q40524854)

English

Current status of Taxotere (docetaxel) as a new treatment in breast cancer

scientific article published on January 1995

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

21 September 2017

1 reference

Europe PubMed Central

Current status of Taxotere (docetaxel) as a new treatment in breast cancer (English)

1 reference

Europe PubMed Central

PubMed publication ID

21 September 2017

1 reference

based on heuristic

author name string

P Fumoleau

1

1 reference

Europe PubMed Central

PubMed publication ID

21 September 2017

B Chevallier

2

1 reference

Europe PubMed Central

PubMed publication ID

21 September 2017

P Kerbrat

3

1 reference

Europe PubMed Central

PubMed publication ID

21 September 2017

V Dieras

4

1 reference

Europe PubMed Central

PubMed publication ID

21 September 2017

N Azli

5

1 reference

Europe PubMed Central

PubMed publication ID

21 September 2017

M Bayssas

6

1 reference

Europe PubMed Central

PubMed publication ID

21 September 2017

M Van Glabbeke

7

1 reference

Europe PubMed Central

PubMed publication ID

21 September 2017

language of work or name

0 references

publication date

1 January 1995

1 reference

Europe PubMed Central

PubMed publication ID

21 September 2017

Breast Cancer Research and Treatment

1 reference

Europe PubMed Central

PubMed publication ID

21 September 2017

33

1 reference

Europe PubMed Central

PubMed publication ID

21 September 2017

1

1 reference

Europe PubMed Central

PubMed publication ID

21 September 2017

39-46

1 reference

Europe PubMed Central

PubMed publication ID

21 September 2017

https://scigraph.springernature.com/pub.10.1007/bf00666069

0 references

High-dose consolidation therapy with autologous stem cell rescue in stage IV breast cancer

1 reference

https://pubmed.ncbi.nlm.nih.gov/7749131

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Phase II study of weekly edatrexate as first-line chemotherapy for metastatic breast cancer: a National Cancer Institute of Canada Clinical Trials Group study

1 reference

https://pubmed.ncbi.nlm.nih.gov/7749131

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Experimental antitumor activity of taxotere (RP 56976, NSC 628503), a taxol analogue

1 reference

https://pubmed.ncbi.nlm.nih.gov/7749131

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Chemotherapy of breast cancer a general overview

1 reference

https://pubmed.ncbi.nlm.nih.gov/7749131

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Phase I and pharmacokinetic study of taxotere (RP 56976) administered as a 24-hour infusion

1 reference

https://pubmed.ncbi.nlm.nih.gov/7749131

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Phase II trial of weekly intravenous vinorelbine in first-line advanced breast cancer chemotherapy

1 reference

https://pubmed.ncbi.nlm.nih.gov/7749131

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Studies With RP 56976 (Taxotere): A Semisynthetic Analogue of Taxol

1 reference

https://pubmed.ncbi.nlm.nih.gov/7749131

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Phase II Trial of Taxol, an Active Drug in the Treatment of Metastatic Breast Cancer

1 reference

https://pubmed.ncbi.nlm.nih.gov/7749131

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Coping with toxicities of docetaxel (Taxotere)

1 reference

https://pubmed.ncbi.nlm.nih.gov/7749131

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Phase I and pharmacokinetic study of Taxotere (RP 56976; NSC 628503) given as a short intravenous infusion

1 reference

https://pubmed.ncbi.nlm.nih.gov/7749131

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Phase I clinical trial of taxotere administered as either a 2-hour or 6-hour intravenous infusion

1 reference

https://pubmed.ncbi.nlm.nih.gov/7749131

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Phase I trial of Taxotere: five-day schedule

1 reference

https://pubmed.ncbi.nlm.nih.gov/7749131

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.1007/BF00666069

1 reference

Europe PubMed Central

PubMed publication ID

21 September 2017

Dimensions Publication ID

0 references

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

21 September 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q40524854&oldid=1899891310"